Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diabetic retinopathy: Effects of melatonin on visual function and circadian rhythm
2015-003955-23Phase 3Completed
- Sponsor
- Rigshospitalet Glostrup
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in diabetic retinopathy (DR) and sleep disorder, sponsored by Rigshospitalet Glostrup. Primary endpoint: Progression of diabetic retinopathy by ERG. Started Feb 2016; status: completed.
02
Drugs
melatonin
03
Conditions
diabetic retinopathy (DR)sleep disorder
Beyond the preview
Go deeper on 2015-003955-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003955-23.